HEADER CELL CYCLE 06-NOV-00 1G6G TITLE X-RAY STRUCTURE OF THE N-TERMINAL FHA DOMAIN FROM S. CEREVISIAE RAD53P TITLE 2 IN COMPLEX WITH A PHOSPHOTHREONINE PEPTIDE AT 1.6 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE RAD53; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN (INCLUDING FHA DOMAIN); COMPND 5 EC: 2.7.1.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SER-LEU-GLU-VAL-TPO-GLU-ALA-ASPALA-THR-PHE-ALA-LYS; COMPND 9 CHAIN: E, F; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 GENE: RAD53; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET22B; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS BETA-SANDWICH, PHOSPHOPEPTIDE COMPLEX, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR D.DUROCHER,I.A.TAYLOR REVDAT 4 30-OCT-24 1G6G 1 LINK REVDAT 3 24-FEB-09 1G6G 1 VERSN REVDAT 2 01-APR-03 1G6G 1 JRNL REVDAT 1 13-DEC-00 1G6G 0 JRNL AUTH D.DUROCHER,I.A.TAYLOR,D.SARBASSOVA,L.F.HAIRE,S.L.WESTCOTT, JRNL AUTH 2 S.P.JACKSON,S.J.SMERDON,M.B.YAFFE JRNL TITL THE MOLECULAR BASIS OF FHA DOMAIN:PHOSPHOPEPTIDE BINDING JRNL TITL 2 SPECIFICITY AND IMPLICATIONS FOR PHOSPHO-DEPENDENT SIGNALING JRNL TITL 3 MECHANISMS. JRNL REF MOL.CELL V. 6 1169 2000 JRNL REFN ISSN 1097-2765 JRNL PMID 11106755 JRNL DOI 10.1016/S1097-2765(00)00114-3 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 46615 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2490 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2116 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 441 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.010 ; NULL REMARK 3 ANGLE DISTANCE (A) : 1.377 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1G6G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-NOV-00. REMARK 100 THE DEPOSITION ID IS D_1000012292. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49229 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.570 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000 MME, AMMONIUM SULPHATE, REMARK 280 SODIUM ACETATE, PH 4.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 16.59550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.73350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.80450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.73350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 16.59550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.80450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 29 REMARK 465 GLU B 30 REMARK 465 ASN B 31 REMARK 465 ALA E 9 REMARK 465 THR E 10 REMARK 465 PHE E 11 REMARK 465 ALA E 12 REMARK 465 LYS E 13 REMARK 465 SER F 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 367 O HOH A 369 1.65 REMARK 500 O HOH E 24 O HOH E 25 1.84 REMARK 500 O HOH A 167 O HOH A 368 1.86 REMARK 500 O HOH A 286 O HOH A 300 1.89 REMARK 500 O HOH A 204 O HOH A 296 1.89 REMARK 500 O HOH A 283 O HOH A 342 1.93 REMARK 500 O HOH B 237 O HOH B 249 1.94 REMARK 500 N ILE B 32 O HOH B 189 1.95 REMARK 500 O HOH A 334 O HOH A 355 1.95 REMARK 500 O HOH A 246 O HOH A 350 1.98 REMARK 500 O HOH F 209 O HOH F 281 2.01 REMARK 500 O HOH A 238 O HOH A 274 2.01 REMARK 500 O HOH B 268 O HOH B 269 2.01 REMARK 500 O HOH B 206 O HOH B 259 2.05 REMARK 500 OD1 ASN A 31 O HOH A 367 2.13 REMARK 500 O HOH B 218 O HOH B 272 2.15 REMARK 500 O HOH A 276 O HOH A 362 2.16 REMARK 500 O HOH A 323 O HOH A 396 2.16 REMARK 500 O HOH E 40 O HOH E 41 2.17 REMARK 500 O HOH B 246 O HOH B 274 2.19 REMARK 500 O HOH A 200 O HOH A 385 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 N LEU F 2 O HOH B 249 1455 1.88 REMARK 500 O HOH A 214 O HOH A 321 4455 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER B 61 -26.25 -33.19 REMARK 500 ALA F 9 -98.20 -128.58 REMARK 500 REMARK 500 REMARK: NULL DBREF 1G6G A 29 155 UNP P22216 RAD53_YEAST 29 155 DBREF 1G6G B 29 155 UNP P22216 RAD53_YEAST 29 155 DBREF 1G6G E 1 13 PDB 1G6G 1G6G 1 13 DBREF 1G6G F 1 13 PDB 1G6G 1G6G 1 13 SEQRES 1 A 127 GLY GLU ASN ILE VAL CYS ARG VAL ILE CYS THR THR GLY SEQRES 2 A 127 GLN ILE PRO ILE ARG ASP LEU SER ALA ASP ILE SER GLN SEQRES 3 A 127 VAL LEU LYS GLU LYS ARG SER ILE LYS LYS VAL TRP THR SEQRES 4 A 127 PHE GLY ARG ASN PRO ALA CYS ASP TYR HIS LEU GLY ASN SEQRES 5 A 127 ILE SER ARG LEU SER ASN LYS HIS PHE GLN ILE LEU LEU SEQRES 6 A 127 GLY GLU ASP GLY ASN LEU LEU LEU ASN ASP ILE SER THR SEQRES 7 A 127 ASN GLY THR TRP LEU ASN GLY GLN LYS VAL GLU LYS ASN SEQRES 8 A 127 SER ASN GLN LEU LEU SER GLN GLY ASP GLU ILE THR VAL SEQRES 9 A 127 GLY VAL GLY VAL GLU SER ASP ILE LEU SER LEU VAL ILE SEQRES 10 A 127 PHE ILE ASN ASP LYS PHE LYS GLN CYS LEU SEQRES 1 B 127 GLY GLU ASN ILE VAL CYS ARG VAL ILE CYS THR THR GLY SEQRES 2 B 127 GLN ILE PRO ILE ARG ASP LEU SER ALA ASP ILE SER GLN SEQRES 3 B 127 VAL LEU LYS GLU LYS ARG SER ILE LYS LYS VAL TRP THR SEQRES 4 B 127 PHE GLY ARG ASN PRO ALA CYS ASP TYR HIS LEU GLY ASN SEQRES 5 B 127 ILE SER ARG LEU SER ASN LYS HIS PHE GLN ILE LEU LEU SEQRES 6 B 127 GLY GLU ASP GLY ASN LEU LEU LEU ASN ASP ILE SER THR SEQRES 7 B 127 ASN GLY THR TRP LEU ASN GLY GLN LYS VAL GLU LYS ASN SEQRES 8 B 127 SER ASN GLN LEU LEU SER GLN GLY ASP GLU ILE THR VAL SEQRES 9 B 127 GLY VAL GLY VAL GLU SER ASP ILE LEU SER LEU VAL ILE SEQRES 10 B 127 PHE ILE ASN ASP LYS PHE LYS GLN CYS LEU SEQRES 1 E 13 SER LEU GLU VAL TPO GLU ALA ASP ALA THR PHE ALA LYS SEQRES 1 F 13 SER LEU GLU VAL TPO GLU ALA ASP ALA THR PHE ALA LYS MODRES 1G6G TPO E 5 THR PHOSPHOTHREONINE MODRES 1G6G TPO F 5 THR PHOSPHOTHREONINE HET TPO E 5 11 HET TPO F 5 11 HETNAM TPO PHOSPHOTHREONINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 3 TPO 2(C4 H10 N O6 P) FORMUL 5 HOH *441(H2 O) HELIX 1 1 ASP A 51 GLU A 58 1 8 HELIX 2 2 VAL A 136 ILE A 140 5 5 HELIX 3 3 ASN A 148 LEU A 155 1 8 HELIX 4 4 ASP B 51 GLU B 58 1 8 HELIX 5 5 VAL B 136 ILE B 140 5 5 HELIX 6 6 ASN B 148 CYS B 154 1 7 SHEET 1 A 6 ARG A 46 ALA A 50 0 SHEET 2 A 6 ASN A 31 CYS A 38 -1 N ASN A 31 O ALA A 50 SHEET 3 A 6 LEU A 141 ILE A 147 -1 O VAL A 144 N ILE A 37 SHEET 4 A 6 GLU A 129 VAL A 132 -1 N ILE A 130 O LEU A 143 SHEET 5 A 6 TRP A 110 LEU A 111 -1 N TRP A 110 O THR A 131 SHEET 6 A 6 GLN A 114 LYS A 115 -1 O GLN A 114 N LEU A 111 SHEET 1 B 5 TYR A 76 HIS A 77 0 SHEET 2 B 5 LYS A 64 GLY A 69 1 O THR A 67 N TYR A 76 SHEET 3 B 5 PHE A 89 LEU A 93 -1 O PHE A 89 N PHE A 68 SHEET 4 B 5 LEU A 99 ASP A 103 -1 O LEU A 100 N LEU A 92 SHEET 5 B 5 GLN A 122 LEU A 123 -1 O GLN A 122 N LEU A 101 SHEET 1 C 6 ARG B 46 LEU B 48 0 SHEET 2 C 6 CYS B 34 CYS B 38 -1 O CYS B 34 N LEU B 48 SHEET 3 C 6 LEU B 141 ILE B 147 -1 N VAL B 144 O ILE B 37 SHEET 4 C 6 GLU B 129 VAL B 132 -1 N ILE B 130 O LEU B 143 SHEET 5 C 6 THR B 109 LEU B 111 -1 N TRP B 110 O THR B 131 SHEET 6 C 6 GLN B 114 LYS B 115 -1 O GLN B 114 N LEU B 111 SHEET 1 D 5 TYR B 76 HIS B 77 0 SHEET 2 D 5 ILE B 62 GLY B 69 1 O THR B 67 N TYR B 76 SHEET 3 D 5 PHE B 89 GLY B 94 -1 O PHE B 89 N PHE B 68 SHEET 4 D 5 LEU B 99 ASP B 103 -1 O LEU B 100 N LEU B 92 SHEET 5 D 5 GLN B 122 LEU B 123 -1 O GLN B 122 N LEU B 101 LINK C VAL E 4 N TPO E 5 1555 1555 1.33 LINK C TPO E 5 N GLU E 6 1555 1555 1.34 LINK C VAL F 4 N TPO F 5 1555 1555 1.32 LINK C TPO F 5 N GLU F 6 1555 1555 1.31 CRYST1 33.191 79.609 131.467 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.030129 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012561 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007606 0.00000